# Combination Chemotherapy in Treating Young Patients With Acute Lymphoblastic Leukemia

> **NCT00343369** · NA · UNKNOWN · sponsor: **Universitätsklinikum Hamburg-Eppendorf** · enrollment: 550 (estimated)

## Conditions studied

- Leukemia

## Interventions

- **DRUG:** asparaginase
- **DRUG:** cyclophosphamide
- **DRUG:** cytarabine
- **DRUG:** daunorubicin hydrochloride
- **DRUG:** dexamethasone
- **DRUG:** doxorubicin hydrochloride
- **DRUG:** mercaptopurine
- **DRUG:** methotrexate
- **DRUG:** pegaspargase
- **DRUG:** prednisolone
- **DRUG:** teniposide
- **DRUG:** thioguanine
- **DRUG:** vincristine sulfate
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00343369
- **Lead sponsor:** Universitätsklinikum Hamburg-Eppendorf
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2003-01
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 550 (ESTIMATED)
- **Last updated:** 2013-08-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00343369

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00343369, "Combination Chemotherapy in Treating Young Patients With Acute Lymphoblastic Leukemia". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT00343369. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*